- Sanofi-Synthélabo closes takeover of Aventis
- Elf Aquitaine's Sanofi merges with Synthlabo
- Hoechst, Rhone-Poulenc to merge
- BMS joins Sterling, Sanofi on heart projects; agreement later revised
- Aventis co-promotes Byk Gulden's Ciclesonide in US
- Altana, Pharmacia develop and market roflumilast; deal ends
- Pfizer acquires Pharmacia in $59bn all stock deal
- GE acquires Amersham PLC for £5.7bn
- Ciba-Geigy and Sandoz merged in $27 billion deal
- Pfizer launches hostile bid for Warner-Lambert
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.